Logo

Exelixis and Dow AgroSciences Extend Target Discovery Collaboration

Aug 05, 2003

NEW YORK, Aug. 5 (GenomeWeb News) - Exelixis said today that Dow AgroSciences had extended for one-year a collaboration to determine mechanism of action in herbicides.

 

The collaboraton involves identifying gene targets and target screening assays for specific herbicidal compounds using Exelixis' drug discovery technologies and model plant species, the company said.

 

The companies did not disclose financial terms of the agreement, but Exelixis said it will receive milestone payments as well as royalties from products developed through the partnership.

Breaking News
The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.